Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer?

Curr Oncol. 2012 Oct;19(5):e303-4. doi: 10.3747/co.19.1009.

Authors

I Kuchuk¹, M Clemons, C Addison

Affiliation

¹ Division of Medical Oncology, The Ottawa Hospital Cancer Centre, and Department of Medicine, University of Ottawa, Ottawa, ON.

No abstract available